Based on these observations, we selected α-Lactalbumin as our model target on breast tumors to test our hypothesis that increase in target protein expression can be facilitated by modulation of hormone receptors on breast tumors which in turn can enhance efficacy of immunotherapy targeted against the tumor. Here, NR4A1 is linked to neoplasm.